Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins

Documenti analoghi

• The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway
  di: Rajanikanth Madabushi, et al.
  Pubblicazione: (2024)
• Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
  di: Ting Wang, et al.
  Pubblicazione: (2025)
• Insights into PK ‐Based Bridging for Products Using a Common Autoinjector Platform: A Review of 16 Autoinjectors in 14 Biological License Applications
  di: Zhe Li, et al.
  Pubblicazione: (2026)
• The Future of Clinical Translational Pharmacology
  di: Matthew L. Rizk, et al.
  Pubblicazione: (2026)
• Model‐Informed Drug Development‐Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non‐Radiographic Axial Spondyloarthritis
  di: Dipak S. Pisal, et al.
  Pubblicazione: (2024)